Comprehensive review of SGLT2 inhibitors’ efficacy through their diuretic mode of action in diabetic patients
SGLT2 inhibitors (SGLT2i) are now the mainstay therapy for both diabetes and heart failure. Post-hoc publications, meta-analysis, and conference presentations of the eight SGLT2i Cardiovascular Outcomes trials (CVOTS) done in diabetic patients constantly echo that this class of drug decreases mortal...
| 主要作者: | |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Frontiers Media S.A.
2023-07-01
|
| 丛编: | Frontiers in Endocrinology |
| 主题: | |
| 在线阅读: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1174692/full |